Cargando…
RV144-like trial in macaques using ALVAC-SIV & gp120 induces innate immunity and increases the frequency of NK22 & NKG2A+ cells in mucosal tissues
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441308/ http://dx.doi.org/10.1186/1742-4690-9-S2-O14 |
_version_ | 1782243261015916544 |
---|---|
author | Liyanage, NP Pegu, P Gordon, S Cameron, M Foulds, K Doster, M Vaccari, M Koup, R Roederer, M Sékaly, R Franchini, G |
author_facet | Liyanage, NP Pegu, P Gordon, S Cameron, M Foulds, K Doster, M Vaccari, M Koup, R Roederer, M Sékaly, R Franchini, G |
author_sort | Liyanage, NP |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-3441308 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-34413082012-09-18 RV144-like trial in macaques using ALVAC-SIV & gp120 induces innate immunity and increases the frequency of NK22 & NKG2A+ cells in mucosal tissues Liyanage, NP Pegu, P Gordon, S Cameron, M Foulds, K Doster, M Vaccari, M Koup, R Roederer, M Sékaly, R Franchini, G Retrovirology Oral Presentation BioMed Central 2012-09-13 /pmc/articles/PMC3441308/ http://dx.doi.org/10.1186/1742-4690-9-S2-O14 Text en Copyright ©2012 Liyanage et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Oral Presentation Liyanage, NP Pegu, P Gordon, S Cameron, M Foulds, K Doster, M Vaccari, M Koup, R Roederer, M Sékaly, R Franchini, G RV144-like trial in macaques using ALVAC-SIV & gp120 induces innate immunity and increases the frequency of NK22 & NKG2A+ cells in mucosal tissues |
title | RV144-like trial in macaques using ALVAC-SIV & gp120 induces innate immunity and increases the frequency of NK22 & NKG2A+ cells in mucosal tissues |
title_full | RV144-like trial in macaques using ALVAC-SIV & gp120 induces innate immunity and increases the frequency of NK22 & NKG2A+ cells in mucosal tissues |
title_fullStr | RV144-like trial in macaques using ALVAC-SIV & gp120 induces innate immunity and increases the frequency of NK22 & NKG2A+ cells in mucosal tissues |
title_full_unstemmed | RV144-like trial in macaques using ALVAC-SIV & gp120 induces innate immunity and increases the frequency of NK22 & NKG2A+ cells in mucosal tissues |
title_short | RV144-like trial in macaques using ALVAC-SIV & gp120 induces innate immunity and increases the frequency of NK22 & NKG2A+ cells in mucosal tissues |
title_sort | rv144-like trial in macaques using alvac-siv & gp120 induces innate immunity and increases the frequency of nk22 & nkg2a+ cells in mucosal tissues |
topic | Oral Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441308/ http://dx.doi.org/10.1186/1742-4690-9-S2-O14 |
work_keys_str_mv | AT liyanagenp rv144liketrialinmacaquesusingalvacsivgp120inducesinnateimmunityandincreasesthefrequencyofnk22nkg2acellsinmucosaltissues AT pegup rv144liketrialinmacaquesusingalvacsivgp120inducesinnateimmunityandincreasesthefrequencyofnk22nkg2acellsinmucosaltissues AT gordons rv144liketrialinmacaquesusingalvacsivgp120inducesinnateimmunityandincreasesthefrequencyofnk22nkg2acellsinmucosaltissues AT cameronm rv144liketrialinmacaquesusingalvacsivgp120inducesinnateimmunityandincreasesthefrequencyofnk22nkg2acellsinmucosaltissues AT fouldsk rv144liketrialinmacaquesusingalvacsivgp120inducesinnateimmunityandincreasesthefrequencyofnk22nkg2acellsinmucosaltissues AT dosterm rv144liketrialinmacaquesusingalvacsivgp120inducesinnateimmunityandincreasesthefrequencyofnk22nkg2acellsinmucosaltissues AT vaccarim rv144liketrialinmacaquesusingalvacsivgp120inducesinnateimmunityandincreasesthefrequencyofnk22nkg2acellsinmucosaltissues AT koupr rv144liketrialinmacaquesusingalvacsivgp120inducesinnateimmunityandincreasesthefrequencyofnk22nkg2acellsinmucosaltissues AT roedererm rv144liketrialinmacaquesusingalvacsivgp120inducesinnateimmunityandincreasesthefrequencyofnk22nkg2acellsinmucosaltissues AT sekalyr rv144liketrialinmacaquesusingalvacsivgp120inducesinnateimmunityandincreasesthefrequencyofnk22nkg2acellsinmucosaltissues AT franchinig rv144liketrialinmacaquesusingalvacsivgp120inducesinnateimmunityandincreasesthefrequencyofnk22nkg2acellsinmucosaltissues |